Medical Condition News

RSS

People who experience chronic pain during childhood have chronic pain as adults

There is strong evidence showing that individuals who experienced chronic pain during childhood have chronic pain as adults, but few studies have evaluated the characteristics of pain that persists from childhood through adult years. Researchers from the University of Michigan found that one in six adult pain patients had pain as children or adolescents, and their pain was widespread and neuropathic with psychological comorbidities and decreased function.

20 Dec 2013

Simple tool right in your back pocket may help decrease type 2 diabetes risks

New University of Michigan research says that a simple tool right in your back pocket may help decrease your risk for type 2 diabetes: Text messages on your phone.

20 Dec 2013

Researchers identify molecular link between liver cancer, obesity, alcoholism, and hepatitis

Obesity, alcoholism, and chronic hepatitis all increase the risk of getting liver cancer, which is the third leading cause of cancer death worldwide. Obesity in particular is driving a significant increase in liver cancer in the United States.

20 Dec 2013

Study: Standard treatment approaches yield modest to large improvement in TMD patients

empromandibular pain disorders (TMDs) are characterized by a dysfunction of the TMD joint and cause orofacial pain, masticatory dysfunction or both.

20 Dec 2013

New MRI approach can be important tool for diagnosing, tracking MS progression

New imaging research from Western University (London, Canada) has demonstrated that a magnetic resonance imaging approach called quantitative susceptibility mapping can be an important tool for diagnosing and tracking the progression of Multiple Sclerosis and other neurological diseases.

20 Dec 2013

New research assesses nanomedicine-based approaches for treating cancer

As cancer maintains its standing as the second leading cause of death in the U.S., researchers have continued their quest for safer and more effective treatments. Among the most promising advances has been the rise of nanomedicine, the application of tiny materials and devices whose sizes are measured in the billionths of a meter to detect, diagnose and treat disease.

20 Dec 2013

Researchers discover cancer-killing properties of frankincense in ovarian cancer

Researchers from the University of Leicester have, for the first time, demonstrated the potential of treating ovarian cancer using the Christmas gift frankincense.

20 Dec 2013

Most dementia people living at home have multiple unmet health and welfare needs

Most people with dementia who live at home have multiple unmet health and welfare needs, any number of which could jeopardize their ability to remain home for as long as they desire, new Johns Hopkins research suggests.

20 Dec 2013

Takeda to acquire exclusive license to develop Natrogen's Natura-alpha compound

Takeda Pharmaceutical Company Limited and Natrogen Therapeutics International, Inc. jointly announced today an agreement whereby Takeda will acquire an exclusive license to develop Natrogen's Natura-alpha compound as well as an option to acquire Natrogen. Natura-alpha is a synthetic small molecule oral compound that is believed to inhibit pro-inflammatory cytokine expression, which may help to reduce gastrointestinal inflammation. Natura-alpha is currently in Phase 2 development for the treatment of ulcerative colitis.

20 Dec 2013

BeiGene doses first patient in Phase 1 study of BGB-283

BeiGene (Beijing), Co., Ltd., today announced dose administration for the first patient in a Phase 1 study of BGB-283 in patients with B-RAF or K-RAS mutations. BGB-283 is an investigational, oral, selective, potent second generation inhibitor of B-RAF, making it a targeted therapeutic candidate to potentially treat and bring benefit to patients with cancers that harbor BRAF mutations and/or aberrations in the RAS-MAPK (mitogen-activated protein kinase) pathway.

20 Dec 2013

FDA approves Baxter's FEIBA for prophylactic treatment of hemophilia patients with inhibitors

Baxter International Inc. today announced that the United States Food and Drug Administration granted approval of Baxter's FEIBA [Anti-Inhibitor Coagulant Complex], the first and only FDA-approved treatment for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in patients with hemophilia A or B who have developed inhibitors.

From Baxter International Inc. 20 Dec 2013

Patient assessment of clinical services quality predicts survival for colorectal cancer patients

Patient assessment of clinical services quality was shown to be an independent predictor of survival for colorectal cancer patients in a study recently published in the Journal of Healthcare Quality, the peer reviewed publication of the National Association for Healthcare Quality (NAHQ), www.nahq.org.

20 Dec 2013

Study finds 87% of teens who quit chewing gum experience relief of migraine headache

Teenagers are notorious for chewing a lot of gum. The lip smacking, bubble popping, discarded gum stuck to the sole give teachers and parents a headache.

20 Dec 2013

Researchers receive Doris Duke Foundation award to predict sickle cell crisis, monitor treatments

Researchers at Case Western Reserve University have received a $486,000 Doris Duke Foundation award to discover how to predict when sickle cell disease patients will suffer an acute crisis and monitor the effectiveness of treatments.

20 Dec 2013

Australian Therapeutic Goods Administration approves Genzyme's Lemtrada for multiple sclerosis

Genzyme, a Sanofi company, announced today that the Australian Therapeutic Goods Administration has approved Lemtrada (alemtuzumab) for the treatment of relapsing forms of multiple sclerosis for patients with active disease defined by clinical or imaging features to slow the accumulation of physical disability and reduce the frequency of clinical relapses.

19 Dec 2013

Blaze Bioscience to initiate first Phase 1 clinical study of BLZ-100 in patients with skin tumors

Blaze Bioscience, Inc. and its subsidiary, Blaze Bioscience Australia Pty Ltd, today announced the initiation of the first Phase 1 clinical study of the first Tumor Paint product candidate, BLZ-100. The study, titled "A Phase I Dose Escalation/Expansion Study of BLZ-100 Administered by Intravenous Injection in Adult Subjects with Skin Cancer," will enroll up to 30 patients with basal cell carcinoma, squamous cell carcinoma, or amelanotic melanoma.

19 Dec 2013

Copenhagen scientists study link between congenital arrhythmia and hypoglycemia

In a new study, scientists from University of Copenhagen document a connection between congenital arrhythmia and the bodies' ability to handle sugar. The results can be of vital importance for patients with the disease and for the future treatment of diabetes. The new study has just been published in the scientific journal Diabetes.

19 Dec 2013

EORTC, GIMEMA clinical trial results show high-dose cytarabine improves outcome in AML patients

Results of the EORTC and GIMEMA AML-12 Trial appearing in the Journal of Clinical Oncology show that high-dose cytarabine in induction treatment improves outcome of adult patients with acute myeloid leukemia.

19 Dec 2013

UVA earns national award for video detailing efforts to improve quality of care for children with asthma

For a video detailing efforts to improve the quality of care for children with asthma, University of Virginia Health System has earned a national award from the Robert Wood Johnson Foundation (RWJF).

19 Dec 2013

GSK team wins Drug Discovery of Year award for developing trametinib for malignant melanoma

The British Pharmacological Society proudly announces that its Drug Discovery of the Year award has been won by the team at GlaxoSmithKline (GSK) responsible for the development of trametinib - a new treatment for malignant melanoma (a type of skin cancer).

19 Dec 2013

Medical Condition News

People who experience chronic pain during childhood have chronic pain as adults

Simple tool right in your back pocket may help decrease type 2 diabetes risks

Researchers identify molecular link between liver cancer, obesity, alcoholism, and hepatitis

Study: Standard treatment approaches yield modest to large improvement in TMD patients

New MRI approach can be important tool for diagnosing, tracking MS progression

New research assesses nanomedicine-based approaches for treating cancer

Researchers discover cancer-killing properties of frankincense in ovarian cancer

Most dementia people living at home have multiple unmet health and welfare needs

Takeda to acquire exclusive license to develop Natrogen's Natura-alpha compound

BeiGene doses first patient in Phase 1 study of BGB-283

FDA approves Baxter's FEIBA for prophylactic treatment of hemophilia patients with inhibitors

Patient assessment of clinical services quality predicts survival for colorectal cancer patients

Study finds 87% of teens who quit chewing gum experience relief of migraine headache

Researchers receive Doris Duke Foundation award to predict sickle cell crisis, monitor treatments

Australian Therapeutic Goods Administration approves Genzyme's Lemtrada for multiple sclerosis

Blaze Bioscience to initiate first Phase 1 clinical study of BLZ-100 in patients with skin tumors

Copenhagen scientists study link between congenital arrhythmia and hypoglycemia

EORTC, GIMEMA clinical trial results show high-dose cytarabine improves outcome in AML patients

UVA earns national award for video detailing efforts to improve quality of care for children with asthma

GSK team wins Drug Discovery of Year award for developing trametinib for malignant melanoma

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News